Polymarket

“Kalshi and Polymarket now let users bet on whether the FDA will approve specific drugs, while Kalshi is also preparing markets tied to clinical-trial outcomes, prompting warnings about insider trading, distorted research incentives, and eroding trust in medical studies.”

“Kalshi and Polymarket now allow traders to wager on FDA drug approvals. Cancer patients are actively pushing back.”